Abstract:Levilactobacillus brevis FZU0713,a potential probiotic previously isolated from the traditional brewing process of Hongqu rice wine,may have the beneficial effects on improving lipid metabolism.This study aimed to evaluate the in vivo protective effects and possible mechanism of L.brevis FZU0713 on the disturbance of lipid metabolism in hyperlipidemic rats fed a high-fat diet(HFD).Results showed that oral administration of L.brevis FZU0713 could significantly inhibit obesity,ameliorate the lipid metabolism disorder,including serum/liver biochemical parameters and hepatic oxidative stress in HFD-fed rats.Histopathological result also indicated that dietary intervention of L.brevis FZU0713 could reduce the accumulation of lipid droplets in liver induced by 8 weeks HFD feeding.Furthermore,L.brevis FZU0713 intervention significantly increased the fecal levels of short-chain fatty acids(SCFAs,including acetate,propionate,butyrate,isobutyrate,valerate and isovalerate)in HFD-fed rats,which may be closely related to the changes of intestinal microbial composition and metabolic function.Intestinal microbiota profiling by 16S rRNA gene sequencing revealed that L.brevis FZU0713 intervention significantly altered the relative abundance of Coprococcus,Butyricicoccus,Intestinimonas,Lachnospiraceae FCS020 group,Ruminococcaceae_NK4A214 group,Ruminococcaceae_UCG-005 and UCG-014 at genus levels.Based on Spearman's rank correlation coefficient,serum and liver lipid metabolism related biochemical parameters were positively correlated with genera Ruminococcus,Pediococcus and Lachnospiraceae,but negatively correlated with genera Pseudoflavonifractor,Butyricicoccus and Intestinimonas.Furthermore,liver metabolomics analysis demonstrated that L.brevis FZU0713 had a significant regulatory effect on the composition of liver metabolites in hyperlipidemic rats,especially the levels of some important biomarkers involved in the metabolic pathways of arachidonic acid metabolism,primary bile acid biosynthesis,amino sugar and nucleotide sugar metabolism,taurine and hypotaurine metabolism,biosynthesis of unsaturated fatty acid,fructose and mannose metabolism,tyrosine metabolism,etc.Additionally,oral administration of L.brevis FZU0713 significantly regulated the mRNA levels of liver genes(including Acat2,Acox1,Hmgcr,Cd36,Srebp-1c and Cyp7a1)involved in lipid metabolism and bile acid homeostasis.In conclusion,our findings provide the evidence that L.brevis FZU0713 has the potential to improve disturbance of lipid metabolism by regulating intestinal microflora and liver metabonomic profile.Therefore,L.brevis FZU0713 may be used as a potential probiotic strain to produce functional food to prevent hyperlipidemia.

Probiotic interventions with highly acid-tolerant Levilactobacillus brevis strains improve lipid metabolism and gut microbial balance in obese mice

<i>Lactobacillus plantarum</i> ZJUFB2 Prevents High Fat Diet-Induced Insulin Resistance in Association With Modulation of the Gut Microbiota

Lactobacillus rhamnosus 069 and Lactobacillus brevis 031: Unraveling Strain-Specific Pathways for Modulating Lipid Metabolism and Attenuating High-Fat-Diet-Induced Obesity in Mice

Probiotic Mixture of Lactobacillus Plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice

Weissella cibaria MG5285 and Lactobacillus reuteri MG5149 attenuated fat accumulation in adipose and hepatic steatosis in high-fat diet-induced C57BL/6J obese mice

Modulation of the Microbiome-Fat-Liver Axis by Lactic Acid Bacteria: A Potential Alleviated Role in High-Fat-Diet-Induced Obese Mice.

Brevibacillus Laterosporus BL1, a Promising Probiotic, Prevents Obesity and Modulates Gut Microbiota in Mice Fed a High-Fat Diet.

Lactic Acid Bacteria Strains Differently Modulate Gut Microbiota and Metabolic and Immunological Parameters in High-Fat Diet-Fed Mice

Lactobacillus fermentum CQPC07 attenuates obesity, inflammation and dyslipidemia by modulating the antioxidant capacity and lipid metabolism in high-fat diet induced obese mice

Lactobacillus gasseri BNR17 and Limosilactobacillus fermentum ABF21069 Ameliorate High Sucrose-Induced Obesity and Fatty Liver via Exopolysaccharide Production and β-oxidation

The Probiotic Kluyveromyces Lactis JSA 18 Alleviates Obesity and Hyperlipidemia in High-Fat Diet C57BL/6J Mice

Lactobacillus plantarum alleviates high-fat diet-induced obesity by altering the structure of mice intestinal microbial communities and serum metabolic profiles

Isolation of Lactobacillus acidophilus strain and its anti-obesity effect in a diet induced obese murine model

Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet-induced obese mice

Efficacy of Probiotic Strains Lactobacillus sakei Probio65 and Lactobacillus plantarum Probio-093 in Management of Obesity: An In Vitro and In Vivo Analysis

The Protective Effects of Levilactobacillus Brevis FZU0713 on Lipid Metabolism and Intestinal Microbiota in Hyperlipidemic Rats

Novel Lactobacillus reuteri HI120 Affects Lipid Metabolism in C57BL/6 Obese Mice

Enterococcus faecium R0026 Combined with Bacillus subtilis R0179 Prevent Obesity-Associated Hyperlipidemia and Modulate Gut Microbiota in C57BL/6 Mice

The Recombinant Lactobacillus Strains with the Surface-Displayed Expression of Amuc_1100 Ameliorate Obesity in High-Fat Diet-Fed Adult Mice

A Mix of Probiotic Strains Prevents Hepatic Steatosis, and Improves Oxidative Stress Status and Gut Microbiota Composition in Obese Mice

Intervention of Five Strains of Lactobacillus on Obesity in Mice Induced by High-Fat Diet